ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 720

$648K Total Retail Price of All Prescriptions

Rank: 7 out of 720

596 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 596 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 596 patients filled at least one prescription for a schedule three drug, compared to an average of 32%.

Risky Drugs to Seniors

4% of this provider’s 6,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 12%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 3.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 542 189 S3 1 1
SIMVASTATIN 325 238 2 2
OMEPRAZOLE 317 248 3 4
METFORMIN HCL 306 245 4 7
TRAMADOL HCL 273 180 5 16
AMLODIPINE BESYLATE 261 210 6 6
LISINOPRIL 253 175 7 3
CARISOPRODOL 237 51 R 8 53
FUROSEMIDE 227 153 9 8
IBUPROFEN 213 116 10 9
GABAPENTIN 190 138 11 15
LEVOTHYROXINE SODIUM 165 112 12 5
BENAZEPRIL HCL 134 98 13 39
ATENOLOL 133 100 14 12
DIOVAN 128 78 15 35
ACETAMINOPHEN-CODEINE 119 68 S3 16 80
DIOVAN HCT 118 73 17 27
ATORVASTATIN CALCIUM 118 91 17 23
ZOLPIDEM TARTRATE 110 67 19 14
PROAIR HFA 107 45 20 50
TAMSULOSIN HCL 105 93 21 38
LOVASTATIN 100 68 22 30
CEPHALEXIN 99 62 23 17
DONEPEZIL HCL 96 89 24 21
FAMOTIDINE 88 62 25 56
TRIAMCINOLONE ACETONIDE 87 59 26 108
HYDROCHLOROTHIAZIDE 85 55 27 10
GLYBURIDE 84 46 R 28 110
LOSARTAN POTASSIUM 83 76 29 28
SPIRIVA 80 18 30 88
MELOXICAM 75 64 31 41
NEXIUM 72 55 32 25
PANTOPRAZOLE SODIUM 70 58 33 60
METOPROLOL TARTRATE 67 49 34 13
MEGESTROL ACETATE 65 64 R 35 201
PREDNISONE 65 36 35 43
OXYCODONE HCL 63 0 S2 37 49
POTASSIUM CHLORIDE 62 38 38 34
RISPERIDONE 61 59 39 78
KLOR-CON 8 61 43 39 134
ALENDRONATE SODIUM 60 58 41 24
LEVOFLOXACIN 60 38 41 52
BACLOFEN 58 46 43 63
VICTOZA 3-PAK 58 40 43 215
VENTOLIN HFA 58 33 43 144
CELEBREX 56 23 46 57
FORTEO 55 55 47 220
NOVOLIN R 54 52 48 168
CARVEDILOL 52 45 49 22
NAMENDA 52 52 49 26
TRAZODONE HCL 50 40 51 89
CLONIDINE HCL 50 37 51 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.